Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Publications
▹
Home
Publication
Heat shock protein 70 is necessary to improve mitochondrial bioenergetics and
reverse diabetic sensory neuropathy following KU-32 therapy.
Authors
Ma J, Farmer KL, Pan P, Urban MJ, Zhao H, Blagg BS, Dobrowsky RT
Submitted By
Rick Dobrowsky on 6/2/2014
Status
Published
Journal
The Journal of pharmacology and experimental therapeutics
Year
2014
Date Published
2/1/2014
Volume : Pages
348 : 281 - 292
PubMed Reference
24263156
Abstract
Impaired neuronal mitochondrial bioenergetics contributes to the
pathophysiologic progression of diabetic peripheral neuropathy (DPN) and may be
a focal point for disease management. We have demonstrated that modulating heat
shock protein (Hsp) 90 and Hsp70 with the small-molecule drug KU-32 ameliorates
psychosensory, electrophysiologic, morphologic, and bioenergetic deficits of DPN
in animal models of type 1 diabetes. The current study used mouse models of type
1 and type 2 diabetes to determine the relationship of changes in sensory neuron
mitochondrial bioenergetics to the onset of and recovery from DPN. The onset of
DPN showed a tight temporal correlation with a decrease in mitochondrial
bioenergetics in a genetic model of type 2 diabetes. In contrast, sensory
hypoalgesia developed 10 weeks before the occurrence of significant declines in
sensory neuron mitochondrial bioenergetics in the type 1 model. KU-32 therapy
improved mitochondrial bioenergetics in both the type 1 and type 2 models, and
this tightly correlated with a decrease in DPN. Mechanistically, improved
mitochondrial function following KU-32 therapy required Hsp70, since the drug
was ineffective in diabetic Hsp70 knockout mice. Our data indicate that changes
in mitochondrial bioenergetics may rapidly contribute to nerve dysfunction in
type 2 diabetes, but not type 1 diabetes, and that modulating Hsp70 offers an
effective approach toward correcting sensory neuron bioenergetic deficits and
DPN in both type 1 and type 2 diabetes.
Investigators with authorship
Name
Institution
Rick Dobrowsky
University of Kansas Medical Center
Complications
All Complications
Bioinformatics
Bone
Cardiomyopathy
Cardiovascular
Gastro-Intestinal (GI)
Nephropathy
Neuropathy & Neurocognition
Pediatric Endocrinology
Retinopathy
Uropathy
Wound Healing
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!